In January, Chief U.S. Judge B. Lynn Winmill ruled St. Luke’s 2012 acquisition of Saltzer Medical Group, one of the largest independent multispecialty groups in Idaho, would cause substantial anticompetitive effects. The judge ordered St. Luke’s to divest Saltzer.
The decision was part of an antitrust case against St. Luke’s that was brought by the Federal Trade Commission, Attorney General Lawrence Wasden and two of St. Luke’s competitors — Saint Alphonsus Health System and Treasure Valley Hospital in Boise.
On June 12, St. Luke’s appealed the January decision, and the court ruled St. Luke’s can continue operating Saltzer while it challenges the rest of the prior ruling that it violated antitrust laws.
More articles on healthcare industry lawsuits:
Appeals court upholds Florida’s ‘docs vs. glocks’ law
Government files Anti-Kickback, False Claims lawsuit against Missouri neurosurgeon
Halifax Health board unanimously votes to settle lawsuit
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
